Next Article in Journal
Inhibition of Enterovirus A71 by a Novel 2-Phenyl-Benzimidazole Derivative
Next Article in Special Issue
High Prevalence of Genogroup I and Genogroup II Picobirnaviruses in Dromedary Camels
Previous Article in Journal
Evidence of BK Polyomavirus Infection in Urothelial but not Renal Tumors from a Single Center Cohort of Kidney Transplant Recipients
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Viruses
Volume 13
Issue 1
10.3390/v13010057
viruses-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Origin and Spread of the Dengue Virus Type 1, Genotype V in Senegal, 2015–2019

by
Idrissa Dieng
1,2,
Marielton dos Passos Cunha
3,
Moussa Moïse Diagne
1,
Pape Mbacké Sembène
2,4,
Paolo Marinho de Andrade Zanotto
3,
Ousmane Faye
1,
Oumar Faye
1,* and
Amadou Alpha Sall
1
1
Arboviruses and Haemorrhagic Fever Viruses Unit, Virology Department, Institut Pasteur de Dakar, Dakar BP 220, Senegal
2
Department of Animal Biology, Faculty of Science et Technics, Université Cheikh Anta Diop de Dakar(UCAD), Fann BP 5005, Dakar, Senegal
3
Laboratory of Molecular Evolution and Bioinformatics, Department of Microbiology, Biomedical Sciences Institute, University of São Paulo, São Paulo 05508-000, Brazil
4
BIOPASS (IRD-CBGP, ISRA, UCAD), Campus de Bel-Air, BP 1386, Dakar CP 18524, Senegal
*
Author to whom correspondence should be addressed.
Viruses 2021, 13(1), 57; https://0-doi-org.brum.beds.ac.uk/10.3390/v13010057
Submission received: 6 November 2020 / Revised: 14 December 2020 / Accepted: 16 December 2020 / Published: 4 January 2021
(This article belongs to the Special Issue Proactive Study of Future Viral Infectious Diseases)
Browse Figures
Versions Notes

Abstract

:
Dengue virus (DENV) is the most widespread arthropod-borne virus, with the number and severity of outbreaks increasing worldwide in recent decades. Dengue is caused by genetically distinct serotypes, DENV-1–4. Here, we present data on DENV-1, isolated from patients with dengue fever during an outbreak in Senegal and Mali (Western Africa) in 2015–2019, that were analyzed by sequencing the envelope (E) gene. The emergence and the dynamics of DENV-1 in Western Africa were inferred by using maximum likelihood and Bayesian methods. The DENV-1 grouped into a monophyletic cluster that was closely related to those from Southeast Asia. The virus appears to have been introduced directly into Medina Gounass (Suburb of Dakar), Senegal (location probability = 0.301, posterior = 0.76). The introduction of the virus in Senegal occurred around 2014 (95% HPD = 2012.88–2014.84), and subsequently, the virus moved to regions within Senegal (e.g., Louga and Fatick), causing intense outbreaks in the subsequent years. The virus appears to have been introduced in Mali (a neighboring country) after its introduction in Senegal. In conclusion, we present evidence that the outbreak caused by DENV-1 in urban environments in Senegal and Mali after 2015 was caused by a single viral introduction from Asia.

1. Introduction

The dengue virus (DENV-1–4) is the world’s most important arbovirus transmitted by infected Aedes mosquitoes. It is endemic in more than 100 countries, and it is estimated that 50 million cases occur annually worldwide [1,2]. Its vector, the Aedes aegypti mosquito, is widely distributed in tropical and subtropical areas around the world [3]. DENV is an enveloped, positive-sense, single-stranded RNA virus that belongs to the genus Flavivirus, family Flaviviridae [4,5]. Its genome has a single open reading frame encoding for three structural proteins (capsid (C), membrane (M) and envelope (E)) and seven non-structural (NS) proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) [6]. Dengue viruses have four antigenically and genetically distinct serotypes, sharing around 65% of genome similarity [7], subsequently subdivided into distinct genotypes [8,9,10]. Dengue virus infection has diverse clinical manifestations, which range from asymptomatic illness to hemorrhagic fever that can culminate in death [11].
Since the first half of the 20th century, all serotypes experienced an increase in genetic diversity [12], causing variations leading to new genotypes with distinct lineages [13,14]. Some studies have revealed associations between genetic diversity and features such as clinical manifestations, virulence and epidemic potential [8,15]. DENV-1 exists in five distinct genotypes (genotypes I–V) [16,17]. Recently, a basal group of DENV-1 with highly divergent sequences was reported, possibly constituting a new genotype (genotype VI) [16].
In Africa, the landscape of DENV circulation was historically dominated by the occurrence of sylvatic DENV-2 [18]. Over the past two decades, a drastic change in epidemiological patterns has been observed in Africa, with urban outbreaks of DENV reported in Senegal [19] and several cases exported to Europe [20]. In Senegal, DENV-1 was first isolated from two cases in 1979 (Digoutte J.P., personal communication). Since then, no studies reported isolation of this serotype. In 2015, a study on malaria in children less than 10 years old allowed for the detection of three DENV-1 cases in Guediawaye (Medina Gounass), in the suburb of Dakar [21]. This was followed two years later by an outbreak, mainly of DENV-1, in Louga city with 131 confirmed cases (submitted paper).
In 2018, another outbreak associated with DENV-1 occurred in Fatick city, Senegal. Since the notification of the first confirmed cases in the Fatick region on 21 September 2018, and as of 27 October 2018, a total of 1740 suspected cases were reported. Among them, 145 were confirmed, and the remaining 1595 were not characterized as DENV-1. Seven districts from four regions have continued to report confirmed cases: Touba (Diourbel region, 105 cases), Diourbel (Diourbel region, 1 case), Mbacke (Diourbel region, 1 case), Fatick (Fatick region, 33 cases), Gossas (Fatick region, 1 case), Coki (Louga region, 1 case) and Richard-Toll (Saint Louis region, 3 cases) [22].
Despite the increased number of sporadic cases and outbreaks in Senegal during the last 10 years, the origin and spread pattern of circulating DENV-1 strains remain unknown. At present, no phylodynamics studies of dengue virus (DENV-1–4) in Senegal have been reported. The present study describes the origin and phylogeographic profile of the DENV-1 epidemiologic spread in Senegal from 2015 to 2019.

2. Materials and Methods

2.1. Ethics Committee

Samples used in this study are part of the Institut Pasteur in Dakar collection (WHO Collaborating Centre for Arboviruses and/or Hemorrhagic Fever Reference and Research). None of the data were directly derived from human samples, but rather from a cell culture supernatant. Therefore, all the samples were anonymous and only isolation IDs were used during the analysis.

2.2. Sample Collection

The strains analyzed during this study were obtained from a cell culture supernatant derived from sporadic DENV cases from 2015 to 2019 and epidemic strains sampled between 2017 and 2018 (Figure 1). Throughout the study, 189 samples were subjected to quantitative reverse transcription PCR (RT-qPCR) to determine serotypes using a TibMolBiol Modular Dx Dengue typing kit (Cat-No. 40-0700-24) (TibMolBiol, Berlin, Germany). Forty-seven were positive for DENV-1, and, of these, a total of 36 isolates from 6 different localities across Senegal and Mali were selected (Table 1) and included in the present study. All other samples belonged to the other serotypes (DENV-2 and DENV-3). No co-infections were detected.

2.3. Virus Isolation

Virus isolation was attempted for samples determined to be positive by RT-qPCR. Two hundred microliters of the sample was diluted 1:10 in Leibovitz’s L-15 medium (L15) and added to a 25 cm2 flask over a monolayer of C6/36 (Aedes albopictus) cell line at 80% confluence, followed by an incubation at 28 °C for 1 h to allow virus adsorption. After incubation, the L15 medium containing 5% FBS, 1% penicillin streptomycin and 0.05% Fungizone was added into a flask and incubated for 10 days or until observation of a cytopathic effect (CPE). To assess viral infection, indirect immunofluorescence (IFA) was conducted as previously described [23]. The flask content was transferred into a 15 mL tube and clarified by low-speed (2500 rpm) centrifugation at 4 °C for 5 min. The supernatant was harvested and stored at −80 °C until further use.

2.4. Molecular Characterization

Viral RNA was extracted from 140 μL of cell culture supernatants using a QIAamp viral RNA kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The extracted RNA was eluted in 60 μL of elution buffer and placed in ice for further use. For cDNA synthesis, 10 μL of viral RNA was mixed with 1 μL of the random hexamer primer (2 pmol), and the mixture was heated at 95 °C for 2 min. Reverse transcription was performed in a 20 μL mixture containing a mix of 2.5 U RNasin (Promega, Madison, WI, USA), 1 μL of desoxynucleotide triphosphate (dNTP) (10 µM each dNTP) and 5 U of AMV reverse transcriptase (Promega, Madison, WI, USA) and incubated at 42 °C for 60 min. PCR products were generated using the set of primers D1E1F/D1E1R, D1E2F/D1E2R and D1E3F/D1E3R [24], which amplify the overlapping fragment of the full E gene region. Five microliters of cDNA was mixed with 10× buffer, 3 μL of each primer, 5 μL of dNTPs (10 µM), 3 μL of MgCl2 and 0.5 μL of Taq polymerase (Promega, Madison, WI, USA).

2.5. Sequencing and Genome Assembly

The obtained amplicons were purified using a QIAquick Spin PCR Purification kit (Qiagen, Hilden, Germany) and then sent for bidirectional sequencing with an ABI 377 automated sequencer (Applied Biosystems, Foster City, CA, USA) to GENEWIZ Services using the same PCR primers. The raw data were then sent to the laboratory for analysis. Chromatograms were analyzed using CodonCode Aligner 3.7.1 (Codon Code, Center Ville, MA, USA) with a Phred quality score cut off of 20 as the cut-off for low-quality sequence trimming.

2.6. Data Sets

The complete E gene sequences available for DENV-1 with information regarding the location and year of isolation were recovered from the National Center for Biotechnology Information (NCBI) (https://0-www-ncbi-nlm-nih-gov.brum.beds.ac.uk/genbank/) website in GenBank format and later converted into FASTA format (sequences available until April 2019). To determine which genotypes and lineages circulated in Senegal and were associated with the outbreak, we resampled the genotypes with large numbers of sequences based on the amount of sequences available for the genotypes that were less sampled (mean of the low sampled genotypes + standard deviation). The genotypes were resampled using the Decrease Redundancy tool hosted at ExPASY (https://www.expasy.org/genomics), with a maximum number of sequences of 5 (n = 5). As a result, we obtained non-redundant representative sequences (n = 59), named dataset-1 (Table S1). Based on the results of the phylogenetic characterization of dataset-1, the outbreak appears to be caused by the monophyletic DENV-1 group in the Southeast Asian clade. To reconstruct the origin and the virus spread in Senegal (Western Africa), we constructed a resampled dataset using all the sequences from the Southeast Asian clade, which included sequences isolated from viruses in different regions of Asia (East Asia, South Asia, Southeast Asia and Western Asia), Africa (Central Africa, East Africa and Southern Africa) and Oceania. Sequences were initially resampled, excluding all identical sequences, following two criteria: (i) when identical from the same location, we kept the oldest sequence (https://biopython.org/wiki/Sequence_Cleaner), and (ii) when identical from more than one distinct location, we kept the sequence in by location following the first criterion (https://www.expasy.org/genomics). In the end, all distinct locations/countries were resampled, including a maximum of 5 sequences per location. The African sequences characterized in this paper were isolated between 2015 and 2019 and combined with re-sampled sequences from a Southeast Asian clade, named dataset-2 (n = 94) (Table S2). All the datasets were aligned using Clustal Omega v.1.2.1 [25]. Recombinant sequences were screened using all the algorithms implemented in the RDP4 program (RDP, GENECONV, BootScan, MaxChi, Chimaera, SiScan and 3 Seq) with default standard settings [26]. The alignment of recombinant free sequences was manually inspected and edited using the program AliView v.1.18.

2.7. Phylogenetic Analysis

Viral phylogenies based on E gene sequences for all the datasets were estimated using the maximum likelihood (ML) phylogenetic approach implemented in IQ-TREE v.1.5.5 software [27] with automatic model selection conducted by ModelFinder using the Bayesian information criterion (BIC) [28]. The robustness of the tree topology was tested during 1000 non-parametric bootstrap analyses. The final tree was visualized and plotted using FigTree v.1.4.3 (http://tree.bio.ed.ac.uk). All sequences used in this work are presented in the following format: genotype/accession number/strain name/locale of isolation/date of isolation.

2.8. Discrete Phylogeographic Inference

We explored the temporal signal (i.e., molecular clock structure) and data quality of dataset-2 with TempEst v.1.5.3 [29]. The spatio-temporal spread of the DENV-1 outbreak in Senegal and Mali was reconstructed under a Bayesian framework implemented in BEAST v.1.10.4 [30] using the general time-reversible model with the gamma-distributed rate variation substitution model (GTR + G), as described by the Akaike information criterion (AIC) in jModelTest v.2.1.10. Based on previous estimates of evolutionary dynamics of related DENV-1, we tested for an uncorrelated relaxed molecular clock, assuming a log-normal distribution, in combination with three non-parametric population growth models: (i) the standard Bayesian skyline plot (BSP; 10 groups), (ii) the Bayesian skyride plot and (iii) the Bayesian skygrid model (Table S3). Phylogeographical patterns and parameters were estimated running the Markov chain Monte Carlo (MCMC) for 50 million states and sampling every 50,000 states with 10% burn-in. MCMC convergence obtained after reaching an effective sample size (ESS) >200 was examined with Tracer v.1.7.1 [31]. Likewise, the maximum clade credibility (MCC) tree was visualized and edited with FigTree v.1.4.4 (http://tree.bio.ed.ac.uk). To calculate the log marginal likelihood for the molecular clock and demographic model selection, we used the path sampling (PS) and stepping-stone (SS) sampling approaches by running 100 path steps of 1 million iterations each.

2.9. Selection Analysis

We analyzed the changes observed in the DENV-1 samples we sequenced, comparing them to the MH679991 from Singapore, using the mixed effects model of evolution (MEME) [32]. We assumed that positive selection for each site can be inferred when the β+ parameter that informs the rate of nonsynonymous substitutions (dN) is greater than α, which informs the rate of synonymous substitutions (dS) using the Datamonkey Adaptive Evolution Server (http://datamonkey.org).

3. Results

In order to gain insight about DENV-1 circulation in Western Africa, we investigated the origin, the mode of spread and the transmission dynamics of DENV-1 circulating in Senegal between 2015 to 2019 (Figure 1) using viral samples obtained across Senegal and Mali (Table 1).
For this study, a total of 36 samples of DENV-1 (Table 1) confirmed by RT-qPCR were amplified, sequenced and aligned with DENV-1 E gene sequences available from GenBank.
The sequences were 1485 nucleotides in length, and no evidence for recombination was found. Synapomorphic amino acid substitutions were observed in 10 out of the 495 sites when the African sequences where compared with the Singapore sequence (the sequence isolated in the Southeast Asian region). Among the amino acid changes, eight were non-conservative and two were conservative (Table 2). Most of the amino acid changes, with the exception of codon site 444, had had β+ > α, suggestive of directional selection, as inferred by the mixed effects model of evolution (MEME).
The maximum likelihood viral genealogy based on dataset-1 revealed that the sequenced strains belonged to a monophyletic group within genotype V. These isolates were associated with sequences from Singapore, Brazil and Puerto Rico (Figure 2).
The phylogeographic analysis of the sequences showed that all the sequenced viruses originated from the Southeast Asian region and were introduced in Medina Gounass, Senegal (location probability = 0.301, posterior = 0.76). It also suggests that a single introduction possibly occurred around 2014.13 (95% HPD = 2012.88–2014.84) and then dispersed to several other regions across the country (i.e., Louga, Fatick, Diourbel and Dakar) and to the neighboring country of Mali (Figure 3).

4. Discussion

The epidemiological pattern of DENV in Africa has changed during the last two decades. This shift has been highlighted by the reports of dengue virus outbreak in all regions across the African continent and/or cases exported to Europe [20]. Between 1970 and 2000, the dengue emergence in Senegal, as in many African countries, was mainly characterized by the circulation of sylvatic DENV-2 with sporadic cases notably in rural areas [18,33,34]. In 2009, a shift appeared with an unprecedented urban DENV-3 epidemic with 196 confirmed cases out of 696 suspected cases across four important cities (i.e., Louga, Fatick, Dakar and Thies) [19]. Since then, between 2017 and 2018, the regular circulation of DENV-1 and DENV-3 occurred in big cities in Senegal [22].
Despite the increased number of DENV cases in Senegal, there were no scientific studies on its origin and dynamics in the region. To our knowledge, this study is the first to elucidate the phylogeny and phylogeography of DENV in Senegal. The amino acid change analysis of sequenced isolates, compared to the Singapore strain (MH679991), identified eight non-conservative amino acid changes located at positions 412, 414, 415, 420, 428, 432, 433 and 444, whereas those at positions 435 and 440 were conservative (Table 2). Although we did not obtain a significant p-value for the codon site analyses, sites 305, 129, 50, 3 and 11 had high values of β+ compared to α, which is suggestive of directional, positive selection, possibly imposed by either humans, vectors or both. The diversification of DENV has been observed over time, and its possible diverse implications, from immune cross-reaction among serotypes to vector competence, have to be taken into account. The phylogenetic inference revealed that the sequenced strains belonged to a monophyletic cluster of genotype V, which likely originated in Asia in the 1940s–1950s [17,35]. This particular genotype is known to be circulating in the Americas and Africa and includes some sequences from West Africa [17,36]. Importantly, genotype V experienced the largest geographic expansion in Africa [37,38]. This was probably followed by its subsequent diversification among a susceptible local population after its introduction from Asia [17].
The phylogeographic reconstruction showed the virus was imported to Medina Gounass, Senegal (location probability = 0.301, posterior = 0.76) from the Southeast Asian region. This region was shown to be an important hub with a pivotal role in the global diffusion of DENV-1 [17] and an important source of dengue virus epidemics across the world [39]. The introduction of DENV-1 in Senegal occurred around 2014.13 (95% HPD = 2012.88–2014.84), and subsequently, the virus moved to regions across the country and neighboring Mali, causing multifocal outbreaks and sporadic cases in the subsequent years [22].
In addition, several serological surveys were conducted, mainly in the Kedougou region (southeastern Senegal), to assess the impact of DENV amplification on human populations. In 1981, 11% of children were positive for antibodies against DENV-2. In addition, positive serological responses were found yearly from 1982 to 1985, particularly in 1984 with 3% positive sera among those tested. IgM antibodies to DENV-2 were detected in November 1988 and November 1991 in 4.6–5.7% and 0.8% of individuals examined, respectively. Authors in [40] reported a high prevalence of the Zika virus antibody during a seroprevalence study in the Dielmo area (located in the Fatick region where a DENV outbreak occurred in 2018). All these previous studies, combined with the frequent molecular detection of other dengue serotypes in Senegal [19,41,42], have stressed that there is a risk of more severe dengue outbreaks in the future, manifesting antibody-dependent enhancement (ADE) as is the case for regions with serotype co-circulation [43]. Our study is the first to report the spatio-temporal dynamics of DENV-1 in Senegal. It highlights the importance of continuous molecular surveillance of arthropod-borne viruses since the spread of emerging pathogens occurs rapidly among distant locations. We hope that this work will constitute a reference for future DENV phylodynamic studies in Senegal. Like Senegal, many other African countries have reported dengue outbreaks [44,45,46], but unfortunately did not provide published sequences. This lack of crucial information begs for large-scale sampling to elucidate the dynamics of DENV across the continent.
The global expansion and recent DENV outbreaks around the world are likely a result of anthropogenic degradation, including unplanned urbanization causing local environmental changes that are resulting in the persistence of the main vector in tropical and subtropical areas [2]. With increasing vector infestation levels, the movement of symptomatic patients, asymptomatic patients and infected vectors may promote the spread of the virus to other localities and ultimately pose a significant risk of its continuous dissemination [10,47]. The increase of DENV activity in Medina Gounass, located in the capital, Dakar, where major financial and administrative activities take place, as well as the increased number of dengue outbreaks in Senegal are clear indications of a serious public health threat with a great potential for economic and public health impacts. Therefore, it is crucial to understand viral movement and to identify transmission hot-spots to allow for both intensive vector surveillance and the adequate design of disease control and prevention strategies [48].

Supplementary Materials

The following are available online at https://0-www-mdpi-com.brum.beds.ac.uk/1999-4915/13/1/57/s1, Table S1: Dengue virus 1 Envelope gene sequences used in the genotype phylogenetic analysis, Table S2: Dengue virus 1 Envelope gene sequences used in the phylogeographic and phylodynamics analysis, Table S3: Model comparison of strict molecular clock and demographic growth models through path sampling (PS) and stepping stone (SS) methods. Bold numbers indicate the best fitting model

Author Contributions

Conceptualization, I.D., M.d.P.C., P.M.d.A.Z., A.A.S., O.F. (Ousmane Faye) and O.F. (Oumar Faye); data curation, I.D. and M.d.P.C.; formal analysis, I.D., M.d.P.C. and M.M.D.; funding acquisition, P.M.d.A.Z. and A.A.S.; methodology, I.D., M.M.D., P.M.d.A.Z., A.A.S. and O.F. (Oumar Faye); resources, A.A.S., O.F. (Ousmane Faye) and O.F. (Oumar Faye); software, I.D., M.d.P.C., M.M.D. and P.M.d.A.Z.; supervision, P.M.d.A.Z., A.A.S., O.F. (Oumar Faye) and P.M.S.; validation, O.F. (Oumar Faye); visualization, I.D., M.d.P.C. and O.F. (Oumar Faye); writing—original draft, I.D.; writing—review and editing, I.D., M.d.P.C., M.M.D., P.M.d.A.Z., A.A.S., P.M.S., O.F. (Ousmane Faye) and O.F. (Oumar Faye). All authors have read and agreed to the published version of the manuscript.

Funding

P.M.d.A.Z. was funded by the Brazilian National Council of Scientific and Technological Development (CNPq) (process no. 441105/2016-5), by the Fiocruz/Pasteur/Aucani-FUSP (process no. 314502) and by the São Paulo Research Foundation (FAPESP) (process no. 2017/23281-6). M.d.P.C. received FAPESP grant: no. 2016/08204-2.

Acknowledgments

We gratefully acknowledge financial support from the Institut Pasteur de Dakar. We thank the Virology Department team at the Institut Pasteur de Dakar.

Conflicts of Interest

The authors have declared that no competing interests exist.

References

  1. Saxena, S.; Kumar, S.; Maurya, V.K.; Bhatt, M.L.B. The Global Distribution and Burden of Dengue and Japanese Encephalitis Co-Infection in Acute Encephalitis Syndrome. Curr. Top. Negl. Trop. Dis. 2019, 496, 504–507. [Google Scholar] [CrossRef] [Green Version]
  2. Messina, J.P.; Brady, O.J.; Scott, T.W.; Zou, C.; Pigott, D.M.; Duda, K.A.; Bhatt, S.; Katzelnick, L.; Howes, R.E.; Battle, K.E.; et al. Global spread of dengue virus types: Mapping the 70 year history. Trends Microbiol. 2014, 22, 138–146. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Kraemer, M.U.; Sinka, M.E.; Duda, K.A.; Mylne, A.Q.; Shearer, F.M.; Barker, C.M.; Hendrickx, G. The global distribution of the arbovirus vectors Aedes aegypti and Ae. albopictus. Elife 2015, 4, e08347. [Google Scholar] [CrossRef]
  4. Gubler, D.J. Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 1998, 11, 480–496. [Google Scholar] [CrossRef] [Green Version]
  5. Guzman, M.G.; Halstead, S.B.; Artsob, H.; Buchy, P.; Farrar, J.; Gubler, D.J.; Hunsperger, E.; Kroeger, A.; Margolis, H.S.; Martínez, E.; et al. Dengue: A continuing global threat. Nat. Rev. Genet. 2010, 8, S7–S16. [Google Scholar] [CrossRef] [Green Version]
  6. Chambers, T.J.; Hahn, C.S.; Galler, R.; Rice, C.M. Flavivirus Genome Organization, Expression, and Replication. Annu. Rev. Microbiol. 1990, 44, 649–688. [Google Scholar] [CrossRef]
  7. Katzelnick, L.C.; Fonville, J.M.; Gromowski, G.D.; Arriaga, J.B.; Green, A.M.; James, S.L.; Lau, L.; Montoya, M.; Wang, C.; VanBlargan, L.A.; et al. Dengue viruses cluster antigenically but not as discrete serotypes. Science 2015, 349, 1338–1343. [Google Scholar] [CrossRef] [Green Version]
  8. Cologna, R.; Armstrong, P.M.; Rico-Hesse, R. Selection for Virulent Dengue Viruses Occurs in Humans and Mosquitoes. J. Virol. 2005, 79, 853–859. [Google Scholar] [CrossRef] [Green Version]
  9. Costa, R.L.; Voloch, C.M.; Schrago, C.G. Comparative evolutionary epidemiology of dengue virus serotypes. Infect. Genet. Evol. 2012, 12, 309–314. [Google Scholar] [CrossRef] [Green Version]
  10. Ortiz-Baez, A.S.; Cunha, M.D.P.; Vedovello, D.; Colombo, T.E.; Nogueira, M.L.; Villabona-Arenas, C.J.; Zanotto, P.M.D.A. Origin, tempo, and mode of the spread of DENV-4 Genotype IIB across the state of São Paulo, Brazil during the 2012–2013 outbreak. Memórias Inst. Oswaldo Cruz 2019, 114. [Google Scholar] [CrossRef]
  11. WHO/TDR. Dengue: Guidelines for Diagnosis, Treatment, Prevention, and Control; World Health Organization: Geneva, Switzerland, 2009; p. 147. [Google Scholar]
  12. Zanotto, P.M.; Gould, E.A.; Gao, G.F.; Harvey, P.H.; Holmes, E.C. Population dynamics of flaviviruses revealed by molecular phylogenies. Proc. Natl. Acad. Sci. USA 1996, 93, 548–553. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Dos Santos, F.B.; De Bruycker-Nogueira, F.; Castro, M.G.; Nunes, P.C.G.; De Filippis, A.M.B.; Faria, N.R.D.C.; Simões, J.B.; Sampaio, S.A.; Santos, C.; Nogueira, R.M.R. First report of multiple lineages of dengue viruses type 1 in Rio de Janeiro, Brazil. Virol. J. 2011, 8, 387. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Holmes, E.C.; Twiddy, S.S. The origin, emergence and evolutionary genetics of dengue virus. Infect. Genet. Evol. 2003, 3, 19–28. [Google Scholar] [CrossRef]
  15. Guzman, M.G.; Gubler, D.J.; Izquierdo, A.; Martinez, E.; Halstead, S.B. Dengue infection. Nat. Rev. Dis. Primers. 2016, 2, 16055. [Google Scholar] [CrossRef]
  16. Pyke, A.T.; Moore, P.R.; Taylor, C.; Hall-Mendelin, S.; Cameron, J.N.; Hewitson, G.R.; Pukallus, D.S.; Huang, B.; Warrilow, D.; Hurk, A.F.V.D. Highly divergent dengue virus type 1 genotype sets a new distance record. Sci. Rep. 2016, 6, 22356. [Google Scholar] [CrossRef] [Green Version]
  17. Arenas, C.J.V.; Zanotto, P.M.D.A. Worldwide Spread of Dengue Virus Type 1. PLoS ONE 2013, 8, e62649. [Google Scholar] [CrossRef] [Green Version]
  18. Gonzalez, J.P.; Du Saussay, C.; Gautun, J.C.; McCormick, J.B.; Mouchet, J. [Dengue in Burkina Faso (ex-Upper Volta): Seasonal epidemics in the urban area of Ouagadougou]. Bull. Soc. Pathol. Exot. Fil. 1985, 78, 7–14. [Google Scholar]
  19. Faye, O.; Ba, Y.; Faye, O.; Al, O.F.E.; Diallo, D.; Chen, R.; Mondo, M.; Ba, R.; Macondo, E.; Siby, T.; et al. Urban Epidemic of Dengue Virus Serotype 3 Infection, Senegal, 2009. Emerg. Infect. Dis. 2014, 20, 456–459. [Google Scholar] [CrossRef]
  20. Were, F. The dengue situation in Africa. Paediatr. Int. Child Heal. 2012, 32, 18–21. [Google Scholar] [CrossRef]
  21. Dieng, I.; Hedible, B.G.; Diagne, M.M.; El Wahed, A.A.; Diagne, C.T.; Fall, C.; Richard, V.; Vray, M.; Weidmann, M.; Faye, O.; et al. Mobile Laboratory Reveals the Circulation of Dengue Virus Serotype I of Asian Origin in Medina Gounass (Guediawaye), Senegal. Diagnostics 2020, 10, 408. [Google Scholar] [CrossRef]
  22. WHO Regional Office for Africa. Weekly Bulletin on Outbreaks and Other Emergences [Internet]. 2018. Available online: http://apps.who.int/iris/bitstream/handle/10665/275620/OEW43-2026102018.pdf (accessed on 31 October 2020).
  23. Digoutte, J.; Calvo-Wilson, M.; Mondo, M.; Traore-Lamizana, M.; Adam, F. Continuous cell lines and immune ascitic fluid pools in arbovirus detection. Res. Virol. 1992, 143, 417–422. [Google Scholar] [CrossRef]
  24. Zheng, K.; Zhou, H.-Q.; Yan, J.; Ke, C.-W.; Maeda, A.; Maeda, J.; Takashima, I.; Kurane, I.; Ma, H.; Xie, X.-M. Molecular characterization of the E gene of dengue virus type 1 isolated in Guangdong province, China, in 2006. Epidemiol. Infect. 2008, 137, 73–78. [Google Scholar] [CrossRef] [Green Version]
  25. Larkin, M.A.; Blackshields, G.; Brown, N.P.; Chenna, R.; Mcgettigan, P.A.; McWilliam, H.; Valentin, F.; Wallace, I.M.; Wilm, A.; Lopez, R.; et al. Clustal W and Clustal X version 2. Bioinformatics 2007, 23, 2947–2948. [Google Scholar] [CrossRef] [Green Version]
  26. Martin, D.P.; Murrell, B.; Golden, M.; Khoosal, A.; Muhire, B. RDP4: Detection and analysis of recombination patterns in virus genomes. Virus Evol. 2015, 1, vev003. [Google Scholar] [CrossRef] [Green Version]
  27. Nguyen, T.H.T.; Clapham, H.; Khanh, L.P.; Nguyen, T.H.Q.; Dinh, T.T.; Tran, V.N.; Whitehead, S.; Simmons, C.P.; Wolbers, M.; Wills, B.A. Methods to discriminate primary from secondary dengue during acute symptomatic infection. BMC Infect. Dis. 2018, 18, 375. [Google Scholar] [CrossRef] [Green Version]
  28. Kalyaanamoorthy, S.; Minh, B.Q.; Wong, T.K.F.; Von Haeseler, A.; Jermiin, L.S. ModelFinder: Fast model selection for accurate phylogenetic estimates. Nat. Methods 2017, 14, 587–589. [Google Scholar] [CrossRef] [Green Version]
  29. Rambaut, A.; Lam, T.T.; Carvalho, L.M.; Pybus, O.G. Exploring the temporal structure of heterochronous sequences using TempEst (formerly Path-O-Gen). Virus Evol. 2016, 2, vew007. [Google Scholar] [CrossRef] [Green Version]
  30. Suchard, M.A.; Lemey, P.; Baele, G.; Ayres, D.L.; Drummond, A.J.; Rambaut, A. Bayesian phylogenetic and phylodynamic data integration using BEAST 1. Virus Evol. 2018, 4, vey016. [Google Scholar] [CrossRef] [Green Version]
  31. Rambaut, A.; Drummond, A.J.; Xie, D.; Baele, G.; Suchard, M.A. Posterior Summarization in Bayesian Phylogenetics Using Tracer 1. Syst. Biol. 2018, 67, 901–904. [Google Scholar] [CrossRef] [Green Version]
  32. Murrell, B.; Wertheim, J.O.; Moola, S.; Weighill, T.; Scheffler, K.; Pond, S.L.K. Detecting Individual Sites Subject to Episodic Diversifying Selection. PLoS Genet. 2012, 8, e1002764. [Google Scholar] [CrossRef] [Green Version]
  33. Diallo, M.; Ba, Y.; Sall, A.A.; Diop, O.M.; Ndione, J.A.; Mondo, M.; Girault, L.; Mathiot, C.; Diallo, M.; Ba, Y.; et al. Amplification of the Sylvatic Cycle of Dengue Virus Type 2, Senegal, 1999–2000: Entomologic Findings and Epidemiologic Considerations. Emerg. Infect. Dis. 2003, 9, 362–367. [Google Scholar] [CrossRef]
  34. Moore, D.L.; Causey, O.R.; Carey, D.E.; Reddy, S.; Cooke, A.R.; Akinkugbe, F.M.; David-West, T.S.; Kemp, G.E. Arthropod-borne viral infections of man in Nigeria, 1964–1970. Ann. Trop. Med. Parasitol. 1975, 69, 49–64. [Google Scholar] [CrossRef]
  35. Cunha, M.D.P.; Guimarães, V.N.; Souza, M.; Cardoso, D.D.D.D.P.; De Almeida, T.N.V.; De Oliveira, T.S.; Fiaccadori, F.S. Phylodynamics of DENV-1 reveals the spatiotemporal co-circulation of two distinct lineages in 2013 and multiple introductions of dengue virus in Goiás, Brazil. Infect. Genet. Evol. 2016, 43, 130–134. [Google Scholar] [CrossRef]
  36. Goncalvez, A.P.; Escalante, A.A.; Pujol, F.H.; Ludert, J.E.; Tovar, D.; Salas, R.A.; Liprandi, F. Diversity and Evolution of the Envelope Gene of Dengue Virus Type 1. Virology 2002, 303, 110–119. [Google Scholar] [CrossRef] [Green Version]
  37. Ayolabi, C.I.; Olusola, B.A.; Ibemgbo, S.A.; Okonkwo, G.O. Detection of Dengue viruses among febrile patients in Lagos, Nigeria and phylogenetics of circulating Dengue serotypes in Africa. Infect. Genet. Evol. 2019, 75, 103947. [Google Scholar] [CrossRef]
  38. Carrasco, C.D.; Niedrig, M.; Gascón, J.; Palacios, G.; Reyes, N.; Malo, M.J.; Wichmann, O.; Ruiz, J.; Schultze, D.; Schunk, M.; et al. Molecular Surveillance of Circulating Dengue Genotypes Through European Travelers. J. Travel Med. 2011, 18, 183–190. [Google Scholar] [CrossRef] [Green Version]
  39. Chen, R.; Vasilakis, N. Dengue—Quo tu et quo vadis? Viruses 2011, 3, 1562–1608. [Google Scholar] [CrossRef] [PubMed]
  40. Ba, F.; Loucoubar, C.; Faye, O.; Fall, G.; Mbaye, R.N.P.N.; Sembene, M.; Diallo, M.; Balde, A.T.; Sall, A.A.; Faye, O. Retrospective analysis of febrile patients reveals unnoticed epidemic of zika fever in Dielmo, Senegal. Clin. Microbiol. Infect. Dis. 2018, 3. [Google Scholar] [CrossRef]
  41. Diagne, C.T.; Barry, M.A.; Ba, Y.; Faye, O.; Sall, A.A. Dengue epidemic in Touba, Senegal: Implications for the Grand Magal Pilgrimage for travellers. J. Travel Med. 2018, 26. [Google Scholar] [CrossRef]
  42. Sokhna, C.; Goumballa, N.; Gautret, P. The Grand Magal of Touba in the time of a dengue outbreak in Senegal. Travel Med. Infect. Dis. 2019, 28, 107–108. [Google Scholar] [CrossRef]
  43. Vinodkumar, C.; Kalapannavar, N.; Basavarajappa, K.; Sanjay, D.; Gowli, C.; Nadig, N.G.; Prasad, B. Episode of coexisting infections with multiple dengue virus serotypes in central Karnataka, India. J. Infect. Public Heal. 2013, 6, 302–306. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  44. Chipwaza, B.; Mugasa, J.P.; Selemani, M.; Amuri, M.; Mosha, F.; Ngatunga, S.D.; Gwakisa, P.S. Dengue and Chikungunya Fever among Viral Diseases in Outpatient Febrile Children in Kilosa District Hospital, Tanzania. PLoS Neglected Trop. Dis. 2014, 8, e3335. [Google Scholar] [CrossRef] [Green Version]
  45. Massangaie, M.; Paweska, J.; Chirindza, C.; Weyer, J.; Gudo, E.S.; Ali, S.; Le Roux, C.; Chilaule, D.; Pinto, G.; Agostinho, S.; et al. Clinical and Epidemiological Characterization of the First Recognized Outbreak of Dengue Virus-Type 2 in Mozambique, 2014. Am. J. Trop. Med. Hyg. 2016, 94, 413–416. [Google Scholar] [CrossRef] [Green Version]
  46. Tarnagda, Z.; Cissé, A.; Bicaba, B.W.; Diagbouga, S.; Sagna, T.; Ilboudo, A.K.; Al, Z.T.E.; Lingani, M.; Sondo, K.A.; Yougbaré, I.; et al. Dengue Fever in Burkina Faso, 2016. Emerg. Infect. Dis. 2018, 24, 170–172. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  47. Stoddard, S.T.; Morrison, A.C.; Vazquez-Prokopec, G.M.; Soldan, V.P.; Kochel, T.J.; Kitron, U.; Elder, J.P.; Scott, T.W. The Role of Human Movement in the Transmission of Vector-Borne Pathogens. PLoS Negl. Trop. Dis. 2009, 3, e481. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  48. Itrat, A.; Khan, A.; Javaid, S.; Kamal, M.; Khan, H.; Javed, S.; Kalia, S.; Khan, A.H.; Sethi, M.I.; Jehan, I. Knowledge, Awareness and Practices Regarding Dengue Fever among the Adult Population of Dengue Hit Cosmopolitan. PLoS ONE 2008, 3, e2620. [Google Scholar] [CrossRef]
Viruses 13 00057 g001 550
Figure 1. A map showing the locations where DENV−1 positive samples were sampled. The red dots correspond to outbreak samples and the blue dots to sporadic samples.
Figure 1. A map showing the locations where DENV−1 positive samples were sampled. The red dots correspond to outbreak samples and the blue dots to sporadic samples.
Viruses 13 00057 g001
Viruses 13 00057 g002 550
Figure 2. Maximum likelihood viral genealogy inferred using the sequences from Senegal and Mali and strains representative of described genotypes. Grey circle on nodes represent bootstrap values greater than 75. The scale bar represents the number of substitutions per site.
Figure 2. Maximum likelihood viral genealogy inferred using the sequences from Senegal and Mali and strains representative of described genotypes. Grey circle on nodes represent bootstrap values greater than 75. The scale bar represents the number of substitutions per site.
Viruses 13 00057 g002
Viruses 13 00057 g003 550
Figure 3. Bayesian discrete phylogeography of dengue strains isolated in Senegal between 2015–2019. Senegalese strains are grouped in a monophyletic cluster (highlighted in red). The black marbles in the nodes represent the posterior probability value and their size is proportional to their value.
Figure 3. Bayesian discrete phylogeography of dengue strains isolated in Senegal between 2015–2019. Senegalese strains are grouped in a monophyletic cluster (highlighted in red). The black marbles in the nodes represent the posterior probability value and their size is proportional to their value.
Viruses 13 00057 g003
Table
Table 1. Sequenced strains during this study.
Table 1. Sequenced strains during this study.
Sequence IDCityCountryYearEpidemiological
Context
307339LougaSenegal2017Outbreak
307424LougaSenegal2017Outbreak
303165LougaSenegal2017Outbreak
302883LougaSenegal2017Outbreak
307419LougaSenegal2017Outbreak
273756DakarSenegal2015Sporadic
297855NAMali2017Outbreak
310386Saint LouisSenegal2018Sporadic
310460DakarSenegal2018Sporadic
313165FatickSenegal2018Outbreak
313167FatickSenegal2018Outbreak
313169FatickSenegal2018Outbreak
313639FatickSenegal2018Outbreak
313644FatickSenegal2018Outbreak
313718FatickSenegal2018Outbreak
313852FatickSenegal2018Outbreak
313943FatickSenegal2018Outbreak
313990FatickSenegal2018Outbreak
313997FatickSenegal2018Outbreak
314074FatickSenegal2018Outbreak
314343FatickSenegal2018Outbreak
314438FatickSenegal2018Outbreak
316359DiourbelSenegal2018Outbreak
316382DiourbelSenegal2018Outbreak
316413DiourbelSenegal2018Outbreak
316447DiourbelSenegal2018Outbreak
316474DiourbelSenegal2018Outbreak
316548DiourbelSenegal2018Outbreak
316647DiourbelSenegal2018Outbreak
316649DiourbelSenegal2018Outbreak
318267LougaSenegal2019Sporadic
318479LougaSenegal2019Sporadic
297914LougaSenegal2017Outbreak
297918LougaSenegal2017Outbreak
297919LougaSenegal2017Outbreak
298272LougaSenegal2017Outbreak
Table
Table 2. Observed codon site substitutions including MH679991 from Singapore. Column 4, Except Isolates (Amino Acid), indicates the sequenced isolates during this study, which show a different amino acid at a given position compared to the remaining; the observed amino acid at this position is indicated in parenthesis. Although not significant at a p-value > 0.05, the mixed effects model of evolution (MEME) suggests that most codon sites had β+ > α, with the exception of codon site 444.
Table 2. Observed codon site substitutions including MH679991 from Singapore. Column 4, Except Isolates (Amino Acid), indicates the sequenced isolates during this study, which show a different amino acid at a given position compared to the remaining; the observed amino acid at this position is indicated in parenthesis. Although not significant at a p-value > 0.05, the mixed effects model of evolution (MEME) suggests that most codon sites had β+ > α, with the exception of codon site 444.
PositionMH679991
(Singapore)		Sequenced Strains during this StudyExcept Isolates (Amino Acid)β+α
3CC314438(S)28.010.07
11FF314438(Y)16.450.00
50VV307424(A)136.690.06
129II310460(T)137.290.00
305SS313990(P)144.250.00
412RM−4.2330.15
414TI−5.450.00
415RL−7.250.00
418TT314438(I)7.620.03
420GW−5.100.03
428GV−5.070.00
432GV−5.070.00
433EG−9.290.00
435WL−4.400.00
440LF−2.890.00
444NY−5.7520.09
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Dieng, I.; Cunha, M.d.P.; Diagne, M.M.; Sembène, P.M.; Zanotto, P.M.d.A.; Faye, O.; Faye, O.; Sall, A.A. Origin and Spread of the Dengue Virus Type 1, Genotype V in Senegal, 2015–2019. Viruses 2021, 13, 57. https://0-doi-org.brum.beds.ac.uk/10.3390/v13010057

AMA Style

Dieng I, Cunha MdP, Diagne MM, Sembène PM, Zanotto PMdA, Faye O, Faye O, Sall AA. Origin and Spread of the Dengue Virus Type 1, Genotype V in Senegal, 2015–2019. Viruses. 2021; 13(1):57. https://0-doi-org.brum.beds.ac.uk/10.3390/v13010057

Chicago/Turabian Style

Dieng, Idrissa, Marielton dos Passos Cunha, Moussa Moïse Diagne, Pape Mbacké Sembène, Paolo Marinho de Andrade Zanotto, Ousmane Faye, Oumar Faye, and Amadou Alpha Sall. 2021. "Origin and Spread of the Dengue Virus Type 1, Genotype V in Senegal, 2015–2019" Viruses 13, no. 1: 57. https://0-doi-org.brum.beds.ac.uk/10.3390/v13010057

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop